Mark A. Berman Better Therapeutics, Inc. (BTTX) insider trading activity

BTTX Quotes by TradingView

Mark A. Berman is Chief Medical Officer of Better Therapeutics, Inc.. Currently has a direct ownership of 448,140 shares of BTTX, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2023, when has been sold 25,362 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 448K
0% 3M change
15.44% 12M change
Total Value Held $0

Mark A. Berman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2023
BUY
Grant, award, or other acquisition
-
25,362 Added 5.36%
448,140 Common Stock
Jul 27 2023
BUY
Open market or private purchase
$40,005 $0.73 p/Share
54,802 Added 12.37%
388,191 Common Stock
Apr 05 2023
BUY
Grant, award, or other acquisition
-
101,450 Added 23.33%
333,389 Common Stock
MAB

Mark A. Berman

Chief Medical Officer
San Francisco, CA

Track Institutional and Insider Activities on BTTX

Follow Better Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Insider Trading

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

News

Receive news related to Better Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTTX